Thymosin Alpha-1: Past Clinical Experience and Future Therapeutic Promise
Updated review of thymosin alpha-1 clinical experience spanning hepatitis B/C, cancer immunotherapy, vaccine adjuvancy, and emerging applications — the most clinically advanced immune peptide drug.
Quick Facts
What This Study Found
Updated review of thymosin alpha-1 clinical experience spanning hepatitis B/C, cancer immunotherapy, vaccine adjuvancy, and emerging applications — the most clinically advanced immune peptide drug.
Key Numbers
How They Did This
research study.
Why This Research Matters
Relevant for peptide research.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
Trust & Context
- Key Stat:
- Key finding Updated review of thymosin alpha-1 clinical experience spanning hepatitis B/C, cancer immunotherapy, vaccine adjuvancy, and emerging applications — th
- Evidence Grade:
- emerging evidence.
- Study Age:
- Published in 2010.
- Original Title:
- Thymosin alpha 1: past clinical experience and future promise.
- Published In:
- Annals of the New York Academy of Sciences, 1194, 130-5 (2010)
- Authors:
- Tuthill, Cynthia(3), Rios, Israel, McBeath, Randy
- Database ID:
- RPEP-01706
Evidence Hierarchy
Frequently Asked Questions
What was studied?
Thymosin Alpha-1: Past Clinical Experience and Future Therapeutic Promise
What was found?
Updated review of thymosin alpha-1 clinical experience spanning hepatitis B/C, cancer immunotherapy, vaccine adjuvancy, and emerging applications — the most clinically advanced immune peptide drug.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01706APA
Tuthill, Cynthia; Rios, Israel; McBeath, Randy. (2010). Thymosin alpha 1: past clinical experience and future promise.. Annals of the New York Academy of Sciences, 1194, 130-5. https://doi.org/10.1111/j.1749-6632.2010.05482.x
MLA
Tuthill, Cynthia, et al. "Thymosin alpha 1: past clinical experience and future promise.." Annals of the New York Academy of Sciences, 2010. https://doi.org/10.1111/j.1749-6632.2010.05482.x
RethinkPeptides
RethinkPeptides Research Database. "Thymosin alpha 1: past clinical experience and future promis..." RPEP-01706. Retrieved from https://rethinkpeptides.com/research/tuthill-2010-thymosin-alpha-1-past
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.